MEKanistic Therapeutics
Led by cancer research pioneers, MEKanistic is advancing a novel class of selective kinase inhibitors rationally designed to target both EGFR and PI3K with a single molecule. This breakthrough design ...load more
MEKanistic Therapeutics's Basic Information
Industry
Headquarters
Minneapolis, Kansas, United States
Website
Employee Insights
MEKanistic Therapeutics's Top Employees
Danny Cunagin
Chief Executive Officer
Phone Email
Frequently Asked Questions Regarding MEKanistic Therapeutics
Connect with anyone with AroundDeal today!
Whether you're looking to connect with key decision-makers or making remote or global hires, we've got you covered.
✔ GDPR aligned & CCPA compliant✔ Cancel anytime✔ 5 free contacts